This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Budesonide

Authoring team

Budesonide is a corticosteroid. It is primarily used as inhaled prophylaxis in asthma but may also be prescribed for the relief of:

  • allergic and vasomotor rhinitis
  • severe skin inflammation, e.g. eczema and psoriasis
  • Crohn's disease affecting the ileum or ascending colon; ulcerative colitis involving rectal and recto-sigmoid disease

Consider budesonide for a first presentation or a single inflammatory exacerbation in a 12‑month period for people:

who have one or more of distal ileal, ileocaecal or right-sided colonic disease and if conventional glucocorticosteroids are contraindicated, or if the person declines or cannot tolerate them. Budesonide is less effective than a conventional glucocorticosteroid, but may have fewer side effects.

Reference

  1. NICE. Crohn’s disease: management. NICE guideline NG129. Published May 2019

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.